Piperine

胡椒碱

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePiperine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 3A inhibitorsP-glycoprotein 1 inhibitors
TargetsCytochrome P450 3AP-glycoprotein 1
Therapy Area/IndicationsMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaProstatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Rochester
Inactive CompaniesN/A
Active IndicationsMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaProstatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A